In 2000, Lu Xianping, 38, joined the first batch of "technology returnees". The ambition is to make original medicines affordable to the Chinese people.

In recent years, due to the support of the national policy, the biomedical industry in our country is becoming the most active industry, and medical research and development can be described with each passing day. In view of the continuous updating of the regulatory policy of the FDA, more and more enterprises and personnel are engaged in pharmaceutical research and development.

According to the 2021 Drug Review Report, there were 908 registration applications for consistency evaluation of quality and efficacy of generic drugs (hereinafter referred to as consistency evaluation applications) in 2021.